Caricamento...
Beyond Telaprevir and Boceprevir: Resistance and New Agents for Hepatitis C Virus Infection
The addition of the hepatitis C virus (HCV) protease inhibitors telaprevir and boceprevir to peginterferon alfa with ribavirin therapy has increased cure rates in HCV infection. Numerous other direct-acting antivirals (DAAs) are in advanced stages of development, including next-generation protease i...
Salvato in:
| Pubblicato in: | Top Antivir Med |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
IAS-USA
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6148907/ https://ncbi.nlm.nih.gov/pubmed/23154254 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|